Skip to main content
COLLEGIUM PHARMACEUTICAL, INC logo

COLLEGIUM PHARMACEUTICAL, INC — Investor Relations & Filings

Ticker · COLL ISIN · US19459J1043 LEI · 54930049FXZMTLW8D496 US Manufacturing
Open in API
Filings indexed 821 across all filing types
Latest filing 2022-04-06 Board/Management Inform…
Country US United States of America
Listing US COLL

About COLLEGIUM PHARMACEUTICAL, INC

https://www.collegiumpharma.com/

Collegium Pharmaceutical, Inc. is a diversified biopharmaceutical company that develops and commercializes medicines for people with serious medical conditions. The company is focused on building a portfolio of differentiated medications. Its primary area of expertise is in pain management, where it develops products with abuse-deterrent properties designed to be safer alternatives for patients and the community.

Recent filings

Filing Released Lang Actions
FORM 8-K
Board/Management Information Classification · 100% confidence The document is a Form 8-K filed with the SEC, dated April 6, 2022, by Collegium Pharmaceutical, Inc. The key content is under Item 5.02, which details the departure and appointment of directors and officers, specifically the appointment of Mr. Neil F. McFarlane as a new director. There is no financial data or report attached; the document is an announcement of a board change. According to the filing definitions, announcements of changes in the company's board of directors or senior management fall under Board/Management Information (MANG). The document length is 4749 characters, which is sufficient to contain substantive information about the board change, not just a brief notice. Therefore, the correct classification is MANG with high confidence.
2022-04-06 English
FORM 8-K
Regulatory Filings Classification · 95% confidence The document is a Form 8-K filed with the SEC, dated April 5, 2022, by Collegium Pharmaceutical, Inc. It announces a press release regarding full-year revenue, adjusted operating expense, and adjusted EBITDA guidance for 2022. The document explicitly states it is a Current Report on Form 8-K and includes forward-looking statements and risk factors. The content is an announcement of financial guidance and a press release, not a full financial report or earnings release. The document length is 8060 characters, which is sufficient for a detailed announcement but it is not a full financial report like a 10-K or interim report. The nature of the filing is a regulatory announcement of a current event, specifically a financial guidance update, which fits the category of Regulatory Filings (RNS) as it does not contain full financial statements or detailed earnings data but is a formal SEC filing reporting a material event.
2022-04-05 English
INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES
Director's Dealing
2022-04-01 English
FORM 8-K
M&A Activity Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a Current Report used to announce major events that shareholders should know about. The content includes details about a merger agreement, completion of acquisition, entry into a material definitive agreement, creation of a direct financial obligation (loan agreement), appointment and departure of officers, and a press release about the acquisition. It also references exhibits such as the merger agreement and loan agreement. The document is not a full annual or quarterly report, nor is it a transcript or earnings release. It primarily announces a merger and related financing and management changes. Therefore, the document fits best into the category of M&A Activity (TAR) because it details merger proposals, tender offers, and acquisition completion. The presence of financing details related to the merger does not override the primary focus on the merger transaction itself. Confidence is high given the explicit references to merger agreement, tender offer, and merger completion.
2022-03-23 English
SC TO-T/A Filing
Regulatory Filings
2022-03-21 English
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
Director's Dealing
2022-03-18 English

Browse filings by year

20 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.